Abbott Laboratories (ABT)
(Delayed Data from NYSE)
$104.51 USD
+0.46 (0.44%)
Updated Dec 8, 2023 04:00 PM ET
After-Market: $104.52 +0.01 (0.01%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth B Momentum D VGM
Price, Consensus and EPS Surprise
ABT 104.51 +0.46(0.44%)
Will ABT be a Portfolio Killer in December?
Zacks Investment Research is releasing its prediction for ABT based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for ABT
Abbott (ABT) Advances While Market Declines: Some Information for Investors
PETQ vs. ABT: Which Stock Is the Better Value Option?
ABT: What are Zacks experts saying now?
Zacks Private Portfolio Services
Abbott (ABT) Rises Higher Than Market: Key Facts
Wall Street Bulls Look Optimistic About Abbott (ABT): Should You Buy?
Should You Invest in the iShares U.S. Medical Devices ETF (IHI)?
Other News for ABT
Abbott Laboratories stock rises Friday, outperforms market
Two babies infected with dangerous bacteria sometimes found in powdered infant formula
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Arvinas Holding Company (ARVN), Abbott Labs (ABT) and Owens & Minor (OMI)
Abbott Laboratories stock falls Thursday, underperforms market
Abbott Laboratories (ABT): A Comprehensive Valuation Assessment